MindMaze Therapeutics Holding SA (RLFTF)

OTC Pharmaceutical Pharmaceutical Preparations SIC: 2834
D
Pipeline Grade

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

No upcoming catalysts detected for this company.

Active Clinical Trials (2)

NCT #TitlePhaseStatusEnrollment
NCT07427511 SwissNeuroRehab - HDHI OTHER Recruiting 120
NCT05728840 Virtual-reality Exercises for Alleviating Attention Deficits in Patients With Acquired Brain Injury OTHER Recruiting 135

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for RLFTF.

SEC EDGAR Filings

All SEC filings for MindMaze Therapeutics Holding SA on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.